MarketCap
Facebook
X
TelegramQuarterly report 2025-Q3
added 11-13-2025
Milestone Scientific Operating Income 2011-2025 | MLSS
Operating profit (also called operating income or profit from core activities) is a financial metric that reflects a company's profit from its main operational activities before interest expenses and taxes are taken into account.
FormulaOperating profit = Revenue – Operating expensesFeatures of the metric
- Evaluates business efficiency
Shows how well the company controls its production and administrative costs. - Independent of financial structure
Excludes the impact of debt burden (interest) and taxes, allowing objective comparison of companies. - Main source for growth
High operating profit provides resources for investments, business expansion, and increased competitiveness.
If a company shows strong operating profit, it signals to investors that the core business is operating efficiently, even if net profit is temporarily reduced due to debt or tax burden.
Annual Operating Income Milestone Scientific
| 2024 | 2023 | 2022 | 2021 | 2020 | 2019 | 2018 | 2017 | 2016 | 2015 | 2014 | 2013 | 2012 | 2011 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| -6.76 M | -7.11 M | -8.83 M | -7.38 M | -7.45 M | -4 M | -8 M | -5.23 M | -6.51 M | -3.06 M | -790 K | 1.09 M | -520 K | -1.22 M |
All numbers in USD currency
Indicator range from annual reports
| Maximum | Minimum | Average |
|---|---|---|
| 1.09 M | -8.83 M | -4.7 M |
Quarterly Operating Income Milestone Scientific
| 2025-Q3 | 2025-Q2 | 2025-Q1 | 2024-Q4 | 2024-Q3 | 2024-Q2 | 2024-Q1 | 2023-Q4 | 2023-Q3 | 2023-Q2 | 2023-Q1 | 2022-Q4 | 2022-Q3 | 2022-Q2 | 2022-Q1 | 2021-Q4 | 2021-Q3 | 2021-Q2 | 2021-Q1 | 2020-Q4 | 2020-Q3 | 2020-Q2 | 2020-Q1 | 2019-Q4 | 2019-Q3 | 2019-Q2 | 2019-Q1 | 2018-Q4 | 2018-Q3 | 2018-Q2 | 2018-Q1 | 2017-Q4 | 2017-Q3 | 2017-Q2 | 2017-Q1 | 2016-Q4 | 2016-Q3 | 2016-Q2 | 2016-Q1 | 2015-Q4 | 2015-Q3 | 2015-Q2 | 2015-Q1 | 2014-Q4 | 2014-Q3 | 2014-Q2 | 2014-Q1 | 2013-Q4 | 2013-Q3 | 2013-Q2 | 2013-Q1 | 2012-Q4 | 2012-Q3 | 2012-Q2 | 2012-Q1 | 2011-Q4 | 2011-Q3 | 2011-Q2 | 2011-Q1 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| -1.13 M | -1.48 M | -2 M | - | -1.47 M | -1.78 M | -1.47 M | - | -1.51 M | -2.28 M | -1.34 M | - | -2.01 M | -2.88 M | -1.91 M | - | -1.98 M | -2.87 M | -984 K | - | -1.48 M | -3.17 M | -1.61 M | - | -947 K | -1.11 M | -818 K | - | -4.55 M | -1.42 M | -2 M | - | -1.41 M | -1.55 M | -526 K | - | -1.57 M | -2.02 M | -943 K | - | -835 K | -1.41 M | -71.1 K | - | -162 K | 47.5 K | 329 K | - | 436 K | 1.46 M | 168 K | - | 51.6 K | -53.6 K | -233 K | - | -540 K | -262 K | -122 K |
All numbers in USD currency
Indicator range from quarterly reporting
| Maximum | Minimum | Average |
|---|---|---|
| 1.46 M | -4.55 M | -1.19 M |
Operating Income of other stocks in the Medical instruments industry
| Issuer | Operating Income | Price | % 24h | Market Cap | Country | |
|---|---|---|---|---|---|---|
 |
Baxter International
BAX
|
14 M | $ 18.99 | 0.48 % | $ 9.68 B |  USA |
 |
Becton, Dickinson and Company
BDX
|
2.58 B | $ 200.87 | 0.22 % | $ 57.8 B | USA |
 |
BioLife Solutions
BLFS
|
-7.13 M | $ 24.43 | -1.81 % | $ 1.13 B | USA |
 |
Ekso Bionics Holdings
EKSO
|
-10.5 M | $ 4.79 | 2.35 % | $ 96.6 M | USA |
 |
DENTSPLY SIRONA
XRAY
|
-879 M | $ 11.59 | -0.13 % | $ 2.36 B | USA |
 |
Alcon
ALC
|
580 M | $ 78.74 | -0.03 % | $ 40.4 B |  Schweiz |
 |
iRhythm Technologies
IRTC
|
-116 M | $ 170.09 | 0.58 % | $ 5.31 B | USA |
 |
AtriCure
ATRC
|
-40 M | $ 42.08 | 1.62 % | $ 1.98 B | USA |
 |
Atrion Corporation
ATRI
|
22.6 K | - | - | $ 810 M | USA |
 |
electroCore
ECOR
|
-19.3 M | $ 4.81 | -0.21 % | $ 26.5 K | USA |
 |
Harvard Bioscience
HBIO
|
1.89 M | $ 0.76 | 1.78 % | $ 32.2 M | USA |
 |
AngioDynamics
ANGO
|
-40 M | $ 13.12 | -2.42 % | $ 536 M | USA |
 |
The Cooper Companies
COO
|
683 M | $ 81.82 | -0.36 % | $ 16.3 B | USA |
 |
ICU Medical
ICUI
|
43 M | $ 147.72 | 0.34 % | $ 3.6 B | USA |
 |
Glaukos Corporation
GKOS
|
-129 M | $ 109.57 | 0.31 % | $ 5.31 B | USA |
 |
Haemonetics Corporation
HAE
|
222 M | $ 83.2 | -1.49 % | $ 4.19 B | USA |
 |
InfuSystem Holdings
INFU
|
1.65 M | $ 9.24 | 0.33 % | $ 191 M | USA |
 |
Isoray
ISR
|
-90.9 M | - | 0.03 % | $ 108 M | USA |
 |
Repro Med Systems
KRMD
|
-10.3 M | $ 5.75 | -1.88 % | $ 262 M | USA |
 |
LeMaitre Vascular
LMAT
|
52.3 M | $ 83.51 | 0.18 % | $ 1.87 B | USA |
 |
Intuitive Surgical
ISRG
|
2.35 B | $ 541.3 | -1.11 % | $ 192 B | USA |
 |
Masimo Corporation
MASI
|
-267 M | $ 138.1 | -2.25 % | $ 7.36 B | USA |
 |
Merit Medical Systems
MMSI
|
156 M | $ 86.52 | -0.01 % | $ 5.04 B | USA |
 |
Microbot Medical
MBOT
|
-9.86 M | $ 2.43 | 2.21 % | $ 24.8 M |  Israel |
 |
Nephros
NEPH
|
-1.59 M | $ 5.08 | 2.24 % | $ 52.8 M | USA |
 |
NeuroMetrix
NURO
|
-8.78 M | - | 5.05 % | $ 9.02 M | USA |
 |
ResMed
RMD
|
1 B | $ 250.7 | -0.67 % | $ 36.6 B | USA |
 |
Envista Holdings Corporation
NVST
|
-1.04 B | $ 21.79 | -1.58 % | $ 3.75 B | USA |
 |
OraSure Technologies
OSUR
|
-28.2 M | $ 2.52 | -2.14 % | $ 188 M | USA |
 |
Pro-Dex
PDEX
|
10.7 M | $ 43.83 | 0.6 % | $ 144 M | USA |
 |
Pulse Biosciences
PLSE
|
-43.6 M | $ 14.26 | 3.71 % | $ 685 M | USA |
 |
Predictive Oncology
POAI
|
-10.9 M | $ 5.95 | 0.51 % | $ 32.4 M | USA |
 |
Repligen Corporation
RGEN
|
47.7 M | $ 156.65 | -3.1 % | $ 8.73 M | USA |
 |
Retractable Technologies
RVP
|
-21.1 M | $ 0.83 | -0.31 % | $ 24.8 M | USA |
 |
STAAR Surgical Company
STAA
|
-12.6 M | $ 24.16 | -2.11 % | $ 1.19 B | USA |
 |
STERIS plc
STE
|
867 M | $ 251.01 | -0.59 % | $ 24.7 B | USA |
 |
Stereotaxis
STXS
|
-21.8 M | $ 2.38 | -1.45 % | $ 192 M | USA |
 |
Teleflex Incorporated
TFX
|
151 M | $ 125.81 | -1.13 % | $ 5.89 B | USA |
 |
Utah Medical Products
UTMD
|
16.8 M | $ 57.99 | 0.5 % | $ 210 M | USA |
 |
West Pharmaceutical Services
WST
|
570 M | $ 266.92 | -2.06 % | $ 19.5 B | USA |